ElevateBio is a cell and gene therapy company that leverages advanced technologies to revolutionize the development of transformative genetic medicines. The company operates an integrated ecosystem that includes multiple research and development platforms and a comprehensive cGMP manufacturing facility, known as BaseCamp, designed to facilitate the discovery and production of innovative therapies. ElevateBio aims to streamline the journey from research to clinical application by providing expertise and capabilities across various therapeutic approaches, including gene editing and cell engineering. Their mission emphasizes the importance of accelerating access to groundbreaking medical technologies, with a vision of becoming a key player in redefining how therapies are developed and diseases are treated. Elevated by a commitment to collaboration and innovation, ElevateBio focuses on creating partnerships that foster scientific advancements and improve patient outcomes.